Intravenous Administration

The World Intellectual Property Organization (WIPO) has published clinical-stage biopharma Tryp Therapeutics Inc. (OTCQB: TRYPF)’s international patent application for the intravenous (IV) administration of psilocybin and psilocin.  The “Improved Methods For The Use of Psychedelics...